Source:http://linkedlifedata.com/resource/pubmed/id/17937990
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2008-1-14
|
pubmed:abstractText |
Herpes Simplex Virus (HSV) infections are among the most common human diseases. In this work, we assess the structural features and electronic properties of a series of ten 1-hydroxyacridone derivatives (1a-j) recently described as a new class of non-nucleoside inhibitors of Herpes Simplex Virus-1 (HSV-1). Based on these molecules, we applied rigid analogue and isosteric replacement approaches to design and synthesize nine new 3H-benzo[b]pyrazolo[3,4-h]-1,6-naphthyridine derivatives (2a-i). The biological and computational results of these new molecules were compared with 1-hydroxyacridones. An inhibitory profile was observed in 10-Cl substituted 3H-benzo[b]pyrazolo[3,4-h]-1,6-naphthyridine derivative (2f), which presents the same substituent at the analogous position of 1-hydroxyacridone derivative (1b). The structure-activity relationship (SAR) studies pointed out the 10-position next to nitrogen atom as important for the anti-HSV-1 profile in the pyrazolo-naphthyridine derivatives tested, which reinforced the promising profile for further experimental investigation. The most potent acridone and pyrazolo-naphthridine derivatives were also submitted to an in silico ADMET screening in order to determine their overall drug-score, which confirmed their potential antiviral profile.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1464-3391
|
pubmed:author |
pubmed-author:AlbuquerqueMagaly GMG,
pubmed-author:AzevedoAlexandre RAR,
pubmed-author:BernardinoAlice M RAM,
pubmed-author:CabralLúcio MLM,
pubmed-author:CastroHelena CHC,
pubmed-author:FrugulhettiIzabel C P PIC,
pubmed-author:GiongoVivecaV,
pubmed-author:LoureiroNatália I VNI,
pubmed-author:MagalhãesUiaran OUO,
pubmed-author:PassamaniFabianaF,
pubmed-author:PinheiroLuiz C SLC,
pubmed-author:RodriguesCarlos RCR,
pubmed-author:SouzaThiago M LTM
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
313-21
|
pubmed:meshHeading |
pubmed-meshheading:17937990-Acridines,
pubmed-meshheading:17937990-Antiviral Agents,
pubmed-meshheading:17937990-Drug Design,
pubmed-meshheading:17937990-Drug Evaluation, Preclinical,
pubmed-meshheading:17937990-Herpesvirus 1, Human,
pubmed-meshheading:17937990-Humans,
pubmed-meshheading:17937990-Naphthyridines,
pubmed-meshheading:17937990-Structure-Activity Relationship
|
pubmed:year |
2008
|
pubmed:articleTitle |
SAR of a series of anti-HSV-1 acridone derivatives, and a rational acridone-based design of a new anti-HSV-1 3H-benzo[b]pyrazolo[3,4-h]-1,6-naphthyridine series.
|
pubmed:affiliation |
Universidade Federal Fluminense, Instituto de Química, Departamento de Química Orgânica, Programa de Pós-Graduação em Química Orgânica, Campus do Valonguinho, 24210-150 Niterói, RJ, Brazil. alicerolim@globo.com
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|